IGSBvsIHE
iShares 1-5 Year Investment Grade Corporate Bond ETF against iShares U.S. Pharmaceuticals ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IGSB | IHE | |
|---|---|---|
| Expense ratio | 0.040% | 0.40% |
| Assets | $23.7B | $1.5B |
| Net flow, 1 month | +$47M | −$130M |
| Net flow, 1 year | +$2.5B | +$666M |
| Return, YTD | -2.6% | +21.8% |
| Return, 1 year | -3.2% | +37.6% |
| Avg daily volume | 4.9M | 274K |
| Holdings | 3892 | 38 |
| Listed | Jan 5, 2007 | May 1, 2006 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS